Navigate NHI, SEP, and Formulary Access With AI-Driven Market Intelligence - Not Guesswork
South Africa's pharmaceutical market access landscape - NHI implementation, Single Exit Price regulations, Essential Medicines List management, and medical scheme formulary negotiation - has never been more complex or consequential. Smart AI Solutions builds AI-powered market access strategy systems for SA pharmaceutical companies.
"We were making formulary and tender pricing decisions based on quarterly market research that was al…"
Siyanda Ntuli, Market Access Director
Your Market Access Decisions Are Based on Fragmented Intelligence While Regulators and Payers Are Moving Fast
South African pharmaceutical market access has entered an era of unprecedented regulatory and commercial complexity. The National Health Insurance Act, evolving SAHPRA pricing regulations, Department of Health Essential Medicines List reviews, and medical scheme formulary rationalisation are all moving simultaneously - creating a market access environment where decisions made without real-time intelligence carry significant revenue risk.
- NHI benefit package determination will fundamentally reshape pricing and access requirements for thousands of medicines - companies without structured NHI intelligence monitoring are making investment decisions without understanding their largest future revenue risk
- Single Exit Price (SEP) annual adjustment submissions require precise health economic modelling - companies submitting without AI-supported economic analysis are systematically under-recovering in SEP negotiations
- Medical scheme formulary decisions affect 8.9 million South African beneficiaries - companies without real-time formulary intelligence and managed care analytics are losing listing positions to competitors who invest in access data
- Public sector tender pricing decisions are made without adequate intelligence on competitor pricing strategies and Essential Medicines List dynamics - resulting in lost tenders or margin-destroying competitive responses
- Health technology assessment (HTA) requirements are increasing - SAHPRA's horizon scanning and HTA framework means companies need health economic evidence packages that most SA pharma teams cannot produce with current resources
Every NHI Benefit Package You Are Not On and Every Formulary You Lose Is Compounding Revenue Loss
For a pharmaceutical product with R45M in annual South African revenue, a medical scheme formulary delisting that affects 30% of the private market represents R13.5M in annual revenue loss. For a product facing NHI benefit package exclusion - which could affect the entire public sector component - the impact is potentially existential. AI market access intelligence that predicts these decisions before they occur costs less than one month of a single lost formulary listing.
Your AI Market Access Intelligence Platform
We build a market access intelligence platform that aggregates regulatory, payer, and competitive intelligence from across the South African healthcare ecosystem - enabling your market access team to make pricing, formulary, and access strategy decisions based on real-time data rather than lagged market research.
Regulatory Intelligence Engine
Continuous monitoring of NHI policy developments, SAHPRA pricing regulations, DoH Essential Medicines List updates, and SEP gazette notices - with AI-generated impact assessments for your product portfolio and prioritised action recommendations for your market access team.
Payer & Formulary Analytics
Real-time formulary position tracking across all major medical schemes - Discovery, Momentum, Medscheme, Bestmed - with competitor formulary movement intelligence, scheme benefit design analysis, and AI-assisted formulary submission optimisation.
Health Economic Modelling Suite
AI-assisted cost-effectiveness and budget impact modelling tools that enable your market access team to build HTA evidence packages, model SEP adjustment scenarios, and prepare reimbursement dossiers - without requiring specialist health economist resources for every product.
Ready to implement this for your Pharmaceutical Companies?
Get My Custom AI Plan"We were making formulary and tender pricing decisions based on quarterly market research that was always 3 months out of date. Smart AI Solutions built us a market access intelligence platform that monitors formulary movements, NHI policy developments, and competitor pricing in real time. We made a tender pricing decision based on AI intelligence that was verified by the actual tender result 6 weeks later - we won at a margin we would not have submitted without the data. The platform has paid for itself many times over."
Siyanda Ntuli
Market Access Director, Limpopo Healthcare Pharma, Polokwane
How It Works
Market Access Landscape Audit & Platform Scoping (Weeks 1-2)
We audit your current market access data sources, formulary monitoring processes, SEP submission methodology, and NHI preparedness. We scope the intelligence platform against your product portfolio priorities and geographic access targets.
Intelligence Platform Build & Data Integration (Weeks 3-6)
We build the regulatory intelligence engine, integrate medical scheme formulary data sources, configure the health economic modelling tools, and build the product portfolio impact dashboard. We connect the platform to your internal sales and market share data for unified market analytics.
Market Access Team Training & Decision Process Integration (Weeks 7-8)
We train your market access team on the platform and integrate intelligence outputs into your pricing committee, tender decision, and formulary submission processes. We configure monthly intelligence briefing reports for your commercial and medical leadership.
Ready to AI Market Access Strategy?
Tell us about your business and we'll create a personalised AI automation plan.
Limited availability - we take on 4 new clients per month
Frequently Asked Questions
Still have questions?
Our team answers every enquiry within one business day.
4 slots left this month
Get My AI Plan